# Pain Relieving Potentials of Combination of Oral Duloxetine and Intravenous Magnesium Sulphate in Post Mastectomy Pain

> **NCT06087211** · NA · COMPLETED · sponsor: **National Cancer Institute, Egypt** · enrollment: 90 (actual)

## Conditions studied

- Duloxetine
- Magnesium Sulphate
- Post-mastectomy Pain Syndrome

## Interventions

- **DRUG:** Magnesium sulphate and Duloxetine
- **DRUG:** Duloxetine
- **DRUG:** Placebo and normal saline

## Key facts

- **NCT ID:** NCT06087211
- **Lead sponsor:** National Cancer Institute, Egypt
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-10
- **Primary completion:** 2025-01-01
- **Final completion:** 2025-01-01
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2025-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06087211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06087211, "Pain Relieving Potentials of Combination of Oral Duloxetine and Intravenous Magnesium Sulphate in Post Mastectomy Pain". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06087211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*